These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9373587)

  • 1. Topical morphine for cutaneous cancer pain.
    Krajnik M; Zylicz Z
    Palliat Med; 1997 Jul; 11(4):325. PubMed ID: 9373587
    [No Abstract]   [Full Text] [Related]  

  • 2. Opioids applied topically to painful cutaneous malignant ulcers in a palliative care setting.
    Zeppetella G; Porzio G; Aielli F
    J Opioid Manag; 2007; 3(3):161-6. PubMed ID: 18027542
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine.
    Mercadante S; Villari P; Ferrera P; Porzio G; Aielli F; Verna L; Casuccio A
    J Pain Symptom Manage; 2006 Aug; 32(2):175-9. PubMed ID: 16877185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Validity of recommended minimum dose of prior morphine to initiate transdermal fentanyl patch in prescribing information - multicenter survey of on prescriptions by palliative care specialists in Japan].
    Hashizume T; Tomiyasu S; Yomiya K; Yoshimoto T; Harada A; Matoba M;
    Gan To Kagaku Ryoho; 2007 Jun; 34(6):897-902. PubMed ID: 17570968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Morphine depot tablets compared with conventional morphine tablets in the treatment of cancer pain].
    Knudsen J; Mortensen SM; Eikard B; Henriksen H
    Ugeskr Laeger; 1985 Feb; 147(9):780-4. PubMed ID: 2580381
    [No Abstract]   [Full Text] [Related]  

  • 6. Opioid rotation from morphine to fentanyl in delirious cancer patients: an open-label trial.
    Morita T; Takigawa C; Onishi H; Tajima T; Tani K; Matsubara T; Miyoshi I; Ikenaga M; Akechi T; Uchitomi Y;
    J Pain Symptom Manage; 2005 Jul; 30(1):96-103. PubMed ID: 16043013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The opioid combination of transdermal fentanyl and sustained release morphine for refractory cancer pain--a case report].
    Shinjo T; Okada M
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1997-2000. PubMed ID: 16282744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commentary: a nursing perspective.
    Derby S
    J Pain Symptom Manage; 1998 Aug; 16(2):134. PubMed ID: 9737106
    [No Abstract]   [Full Text] [Related]  

  • 9. [Transdermal route as an alternative to oral administration of opioids in cancer pain].
    Burza M; Ginobbi P; Fusco G; Laurenzi L; Tirelli W; Arcuri E
    Clin Ter; 1998; 149(4):277-80. PubMed ID: 9866889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Is morphine not used sufficiently in cancer pain? Opiophobia in Sweden].
    Rane A
    Lakartidningen; 1997 Jan; 94(5):321-3. PubMed ID: 9053670
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of pain in cancer patients with continuous infusion of analgesics].
    Drøsdal S
    Tidsskr Nor Laegeforen; 1984 Sep; 104(25):1722-4. PubMed ID: 6207607
    [No Abstract]   [Full Text] [Related]  

  • 12. Opioid switch in palliative care, opioid choice by clinical need and opioid availability.
    Müller-Busch HC; Lindena G; Tietze K; Woskanjan S
    Eur J Pain; 2005 Oct; 9(5):571-9. PubMed ID: 16139186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achieving analgesia for painful ulcers using topically applied morphine gel.
    Tran QN; Fancher T
    J Support Oncol; 2007 Jun; 5(6):289-93. PubMed ID: 17624054
    [No Abstract]   [Full Text] [Related]  

  • 14. Morphine in cancer pain: modes of administration. Expert Working Group of the European Association for Palliative Care.
    BMJ; 1996 Mar; 312(7034):823-6. PubMed ID: 8608293
    [No Abstract]   [Full Text] [Related]  

  • 15. [Usefulness of fentanyl patch (Durotep) in cancer patients when rotated from morphine preparations].
    Akiyama Y; Iseki M; Izawa R; Ishii K; Miyazaki T; Yamaguchi S; Tani Y
    Masui; 2007 Mar; 56(3):317-23. PubMed ID: 17366919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Direct conversion from low-dose morphine to transdermal fentanyl: efficacy for cancer pain and quality of life].
    Yamazaki M; Aoki T; Tachibana M; Akashi T
    Gan To Kagaku Ryoho; 2006 Feb; 33(2):217-21. PubMed ID: 16484859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphine and alternative opioids in cancer pain: the EAPC recommendations.
    Hanks GW; Conno F; Cherny N; Hanna M; Kalso E; McQuay HJ; Mercadante S; Meynadier J; Poulain P; Ripamonti C; Radbruch L; Casas JR; Sawe J; Twycross RG; Ventafridda V;
    Br J Cancer; 2001 Mar; 84(5):587-93. PubMed ID: 11237376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pain in cancer patients].
    Husebø S; Lauritzen G
    Tidsskr Nor Laegeforen; 1986 Nov; 106(33):2860-5. PubMed ID: 2433789
    [No Abstract]   [Full Text] [Related]  

  • 19. Methadone as an additional opioid for a cancer patient with severe neuropathic and bone pain not responsive to other opioids and adjuvant analgesics.
    Leppert W; Kowalski G
    J Palliat Care; 2013; 29(2):119-21. PubMed ID: 23923476
    [No Abstract]   [Full Text] [Related]  

  • 20. The effectiveness of transdermal fentanyl in palliative care.
    Evans R
    Nurs Times; 2003 Oct 14-20; 99(41):24-5. PubMed ID: 14603653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.